U.S. Diagnostic Enzymes Market Size & Outlook, 2024-2030
U.S. diagnostic enzymes market, 2018-2030 (US$M)
Related Markets
U.S. diagnostic enzymes market highlights
- The U.S. diagnostic enzymes market generated a revenue of USD 1,974.8 million in 2024 and is expected to reach USD 2,875.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.5% from 2025 to 2030.
- In terms of segment, glucose oxidase/glucose dehydrogenase was the largest revenue generating type in 2024.
- Lactate dehydrogenase is the most lucrative type segment registering the fastest growth during the forecast period.
Diagnostic enzymes market data book summary
| Market revenue in 2024 | USD 1,974.8 million |
| Market revenue in 2030 | USD 2,875.2 million |
| Growth rate | 6.5% (CAGR from 2025 to 2030) |
| Largest segment | Glucose oxidase/glucose dehydrogenase |
| Fastest growing segment | Lactate dehydrogenase |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Taq polymerase, MMLV RT, HIV RT, Hot start Taq pol, UNG, RNase inhibitor, Bst polymerase (LAMP enzyme), PCR Master Mix, Lyophilised Polymerase, T7 RNA polymerase, Cas9 enzyme, Acid phosphatase, Alanine aminotransferase, Alkaline phosphatase, Amylase, Angiotensin converting enzyme, Aspartate aminotransferase, Cholinesterase, Creatinine kinase, Gamma glutamyl transferase, Lactate dehydrogenase, Renin, Glucose oxidase/glucose dehydrogenase, Urease, Lactate oxidase, Horseradish peroxidase, Glutamate oxidase |
| Key market players worldwide | Takara Bio Inc, Promega, Enzo Biochem Inc, Merck KGaA, Thermo Fisher Scientific Inc, Roche |
Other key industry trends
- In terms of revenue, U.S. accounted for 38.3% of the global diagnostic enzymes market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. diagnostic enzymes market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 305.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Diagnostic Enzymes Market Scope
Diagnostic Enzymes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. diagnostic enzymes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diagnostic enzymes market will help companies and investors design strategic landscapes.
Glucose oxidase/glucose dehydrogenase was the largest segment with a revenue share of 10.36% in 2024. Horizon Databook has segmented the U.S. diagnostic enzymes market based on taq polymerase, mmlv rt, hiv rt, hot start taq pol, ung, rnase inhibitor, bst polymerase (lamp enzyme), pcr master mix, lyophilised polymerase, t7 rna polymerase, cas9 enzyme, acid phosphatase, alanine aminotransferase, alkaline phosphatase, amylase, angiotensin converting enzyme, aspartate aminotransferase, cholinesterase, creatinine kinase, gamma glutamyl transferase, lactate dehydrogenase, renin, glucose oxidase/glucose dehydrogenase, urease, lactate oxidase, horseradish peroxidase, glutamate oxidase covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. diagnostic enzymes market is driven by the increasing adoption of enzyme-based diagnostic tests, advancements in diagnostic technologies, the rise in chronic & infectious diseases, growing demand for point-of-care testing, the use of artificial intelligence & machine learning, and the growing demand for enzyme-based diagnostic tests in clinical chemistry.
For instance, in January 2025, Scientists at the Broad Institute and Cyrus Biotechnology engineered CRISPR nucleases (Cas9 and Cas12) to evade immune detection, reducing potential side effects while maintaining gene-editing efficiency. Using computational modeling, they identified and removed immune-triggering sequences, demonstrating significantly lower immune responses in human cells and mice.
Reasons to subscribe to U.S. diagnostic enzymes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. diagnostic enzymes market databook
-
Our clientele includes a mix of diagnostic enzymes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. diagnostic enzymes market , including forecasts for subscribers. This country databook contains high-level insights into U.S. diagnostic enzymes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. diagnostic enzymes market size, by type, 2018-2030 (US$M)
U.S. Diagnostic Enzymes Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
